200 related articles for article (PubMed ID: 29508417)
21. Tom Ten Have's contributions to causal inference and biostatistics: review and future research directions.
Small DS; Joffe MM; Lynch KG; Roy JA; Russell Localio A
Stat Med; 2014 Sep; 33(20):3421-33. PubMed ID: 23255088
[TBL] [Abstract][Full Text] [Related]
22. Random Forests Approach for Causal Inference with Clustered Observational Data.
Suk Y; Kang H; Kim JS
Multivariate Behav Res; 2021; 56(6):829-852. PubMed ID: 32856937
[TBL] [Abstract][Full Text] [Related]
23. Biomarker threshold adaptive designs for survival endpoints.
Diao G; Dong J; Zeng D; Ke C; Rong A; Ibrahim JG
J Biopharm Stat; 2018; 28(6):1038-1054. PubMed ID: 29436940
[TBL] [Abstract][Full Text] [Related]
24. Causal rule ensemble method for estimating heterogeneous treatment effect with consideration of prognostic effects.
Hiraishi M; Wan K; Tanioka K; Yadohisa H; Shimokawa T
Stat Methods Med Res; 2024 Jun; 33(6):1021-1042. PubMed ID: 38676367
[TBL] [Abstract][Full Text] [Related]
25. Estimating heterogeneous survival treatment effect in observational data using machine learning.
Hu L; Ji J; Li F
Stat Med; 2021 Sep; 40(21):4691-4713. PubMed ID: 34114252
[TBL] [Abstract][Full Text] [Related]
26. Assessing the performance of the generalized propensity score for estimating the effect of quantitative or continuous exposures on binary outcomes.
Austin PC
Stat Med; 2018 May; 37(11):1874-1894. PubMed ID: 29508424
[TBL] [Abstract][Full Text] [Related]
27. Matching algorithms for causal inference with multiple treatments.
Scotina AD; Gutman R
Stat Med; 2019 Jul; 38(17):3139-3167. PubMed ID: 31066079
[TBL] [Abstract][Full Text] [Related]
28. Lessons in biostatistics: inferences and conjectures about average and conditional treatment effects in randomized trials and observational studies.
Bottai M
J Intern Med; 2014 Sep; 276(3):229-37. PubMed ID: 25040872
[No Abstract] [Full Text] [Related]
29. Can the learning health care system be educated with observational data?
Dahabreh IJ; Kent DM
JAMA; 2014 Jul; 312(2):129-30. PubMed ID: 25005647
[No Abstract] [Full Text] [Related]
30. Causal machine learning for predicting treatment outcomes.
Feuerriegel S; Frauen D; Melnychuk V; Schweisthal J; Hess K; Curth A; Bauer S; Kilbertus N; Kohane IS; van der Schaar M
Nat Med; 2024 Apr; 30(4):958-968. PubMed ID: 38641741
[TBL] [Abstract][Full Text] [Related]
31. Machine learning for causal inference in Biostatistics.
Rose S; Rizopoulos D
Biostatistics; 2020 Apr; 21(2):336-338. PubMed ID: 31742360
[No Abstract] [Full Text] [Related]
32. Emulate randomized clinical trials using heterogeneous treatment effect estimation for personalized treatments: Methodology review and benchmark.
Ling Y; Upadhyaya P; Chen L; Jiang X; Kim Y
J Biomed Inform; 2023 Jan; 137():104256. PubMed ID: 36455806
[TBL] [Abstract][Full Text] [Related]
33. Testing causal effects in observational survival data using propensity score matching design.
Lu B; Cai D; Tong X
Stat Med; 2018 May; 37(11):1846-1858. PubMed ID: 29399833
[TBL] [Abstract][Full Text] [Related]
34. Explicit inclusion of treatment in prognostic modeling was recommended in observational and randomized settings.
Groenwold RH; Moons KG; Pajouheshnia R; Altman DG; Collins GS; Debray TP; Reitsma JB; Riley RD; Peelen LM
J Clin Epidemiol; 2016 Oct; 78():90-100. PubMed ID: 27045189
[TBL] [Abstract][Full Text] [Related]
35. Robust estimation of heterogeneous treatment effects using electronic health record data.
Li R; Wang H; Tu W
Stat Med; 2021 May; 40(11):2713-2752. PubMed ID: 33738800
[TBL] [Abstract][Full Text] [Related]
36. Efficient targeted learning of heterogeneous treatment effects for multiple subgroups.
Wei W; Petersen M; van der Laan MJ; Zheng Z; Wu C; Wang J
Biometrics; 2023 Sep; 79(3):1934-1946. PubMed ID: 36416173
[TBL] [Abstract][Full Text] [Related]
37. Studying treatment-effect heterogeneity in precision medicine through induced subgroups.
Sies A; Demyttenaere K; Van Mechelen I
J Biopharm Stat; 2019; 29(3):491-507. PubMed ID: 30794033
[TBL] [Abstract][Full Text] [Related]
38. Personalized treatment selection using data from crossover designs with carry-over effects.
Siriwardhana C; Kulasekera KB; Datta S
Stat Med; 2019 Dec; 38(28):5391-5412. PubMed ID: 31637762
[TBL] [Abstract][Full Text] [Related]
39. Uncovering interpretable potential confounders in electronic medical records.
Zeng J; Gensheimer MF; Rubin DL; Athey S; Shachter RD
Nat Commun; 2022 Feb; 13(1):1014. PubMed ID: 35197467
[TBL] [Abstract][Full Text] [Related]
40. Causal inference on electronic health records to assess blood pressure treatment targets: an application of the parametric g formula.
Johnson KW; Glicksberg BS; Hodos RA; Shameer K; Dudley JT
Pac Symp Biocomput; 2018; 23():180-191. PubMed ID: 29218880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
